301 related articles for article (PubMed ID: 19413083)
21. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
Hughes AD; Jones LH
Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
[TBL] [Abstract][Full Text] [Related]
22. [Trends in modern COPD therapy].
Krankenpfl J; 2005; 43(4-6):116. PubMed ID: 16171062
[No Abstract] [Full Text] [Related]
23. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
Norman P
Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
[TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2005 Jun; (13):1923-47. PubMed ID: 16135316
[No Abstract] [Full Text] [Related]
25. [Chronic-obstructive pulmonary disease. Medical treatment].
Randerath W; Galetke W; Karl-Heinz R
Med Monatsschr Pharm; 2002 May; 25(5):150-8; quiz 158, 168. PubMed ID: 12050920
[No Abstract] [Full Text] [Related]
26. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
27. The economic burden of COPD exacerbations.
Simoens S
COPD; 2010 Jun; 7(3):159-61. PubMed ID: 20486812
[No Abstract] [Full Text] [Related]
28. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
29. Management of chronic obstructive pulmonary disease.
Donohue JF
Curr Opin Pulm Med; 1995 Mar; 1(2):129-43. PubMed ID: 15786603
[TBL] [Abstract][Full Text] [Related]
30. Management of chronic obstructive pulmonary disease.
Mulloy E
Ir Med J; 1996; 89(6):202, 204. PubMed ID: 8996941
[No Abstract] [Full Text] [Related]
31. What is the best pharmacological treatment to prevent exacerbation of chronic obstructive pulmonary disease?
Celli BR
Pol Arch Med Wewn; 2008 Apr; 118(4):172-4. PubMed ID: 18575413
[No Abstract] [Full Text] [Related]
32. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
33. Novel combined candidate--new hopes for COPD maintenance therapy!?
Mihălţan F; Ulmeanu R
Pneumologia; 2015; 64(3):9-11. PubMed ID: 26740985
[No Abstract] [Full Text] [Related]
34. [Maintenance treatment of chronic obstructive pulmonary disease].
Volla TT; Kopperud GS
Tidsskr Nor Laegeforen; 2008 Apr; 128(7):826-8. PubMed ID: 18389030
[TBL] [Abstract][Full Text] [Related]
35. Chronic obstructive pulmonary disease. Part two--management.
Booker R
Nurs Times; 2007 May 1-7; 103(18):28-9. PubMed ID: 17508660
[TBL] [Abstract][Full Text] [Related]
36. Improving COPD management in the nursing home--part 2.
Beecham N; Doherty DE
Director; 2004; 12(1):42, 44-9. PubMed ID: 19178117
[TBL] [Abstract][Full Text] [Related]
37. Role of low-dose theophyllines in exacerbations of COPD.
Palamarthy AB
Thorax; 2010 Mar; 65(3):277; author reply 277. PubMed ID: 20335304
[No Abstract] [Full Text] [Related]
38. Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
Salpeter SR
Can Fam Physician; 2007 Aug; 53(8):1290-7. PubMed ID: 17872838
[No Abstract] [Full Text] [Related]
39. A prescription with the self-management plan - a step too far?
Bolton CE
Chron Respir Dis; 2007; 4(3):129-30. PubMed ID: 17711910
[No Abstract] [Full Text] [Related]
40. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
Black PN; McDonald CF
Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
